Cell And Gene Therapy Manufacturing

1. Thermo Fisher Scientific Single-Use Global Manufacturing Network 4/18/2022

   We have implemented a multi-tier strategy to improve the resiliency of our supply chain and created the largest networked single-use manufacturing organization in the world.

2. Breaking Down Automated Manufacturing 8/18/2023

   Experts explain the general benefits of automated manufacturing as well as the key areas that need improvement to scale up quality and to help reduce the costs of therapeutics.

3. Ultralow Particulate Bottles And Carboys: Where Being Particular About Particulates Is Critical 5/27/2025

   Optimize your operations with ready-to-use, meticulously prepared containers. Learn how our commitment to cleanliness reduces risks and supports your most critical requirements.

4. Perfusion: Medium Selection And Testing 6/16/2025

   An examination of what to consider in a perfusion medium, including varying reconstituted concentrations, supporting multiple cell clones, allowing for high cell densities at low medium exchange rates, and using it in various types of perfusion.

5. Major Advancements In mRNA 1/29/2024

   Experts on this Cell & Gene live event discuss the major scientific biological advances in understanding the potential for mRNA-based immunotherapies vaccines for cancer over the last 2 years.

6. A Collaboration With Fresenius Kabi BioPharm 5/19/2025

   Explore how biosimilar development is advancing through collaboration, innovative cell culture strategies, and the use of advanced media to meet biomanufacturing goals.

7. Manufacturing Hurdles With Viral Vectors 11/13/2023

   With a wide range of viral vector-based drugs already approved, viral vectors are expected to remain the primary delivery mechanism for the foreseeable future. However, as the demand for viral vectors increases, addressing the challenges related to their manufacture and scale-up is critical. In this segment, Dave Maheu, VP, Head of Process & Analytical Development at Candel Therapeutics and Curran Simpson, Chief Operating Officer at REGENXBIO share what they consider to be the most difficult challenges in vector development and manufacturing currently.

8. CTS DynaCellect Cinematic Overview 6/2/2025

   Achieve high cell purity and recovery with an automated, closed magnetic separation system. Learn how this technology helps increase robustness, minimize failures, and streamline cell therapy manufacturing.

9. A Successful Journey To Cell Therapy Manufacturing 5/29/2025

   Learn about the three main areas to consider when you're preparing to commercialize a cell therapy, including starting/raw material, the controlled manufacturing process, as well as testing safety and quality.

10. Optimization Of Anion Exchange Purification For The Large-Scale Production Of Plasmid DNA 11/4/2025

    In this webinar, we discuss pDNA purification, including how to identify optimal conditions for various chromatography media and optimize recovery and impurity removal.